Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

NCT01188486 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01188486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01188486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Terminated
Start date
August 31, 2010
Completion date
April 30, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung cancer non-small cell cancer (nsclc), lung cancer small cell lung cancer (sclc), mesothelioma